HOOKIPA Pharma Stock Discussion

$HOOKIPA Pharma (HOOK.US)$
With Gilead Science holding 15% share, it is worthwhile to hold long...

$HOOKIPA Pharma (HOOK.US)$ Watching for news out of the presentation at SITC 2024 from Saturday!

$HOOKIPA Pharma (HOOK.US)$
HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024
HOOKIPA Pharma (NASDAQ: HOOK) announced that updated Phase 2 data for eseba-vec (HB200) plus pembrolizumab in first-line recurrent/metastatic HPV16-positive head and neck cancer will be presented at SITC 2024. The presentation will be delivered as a late-breaking poster by Dr. Alan Ho, Chief of Head and Neck Oncology Service at Memorial Sloan Cancer Cent...

$HOOKIPA Pharma (HOOK.US)$ Reuters· 2 mins ago
HOOKIPA Pharma Doses First Patients With Eseba-Vec as Adjuvant Therapy in Phase 2 Investigator Lead Trial for Head & Neck Cancer

$HOOKIPA Pharma (HOOK.US)$ HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset
16 MINUTES AGO, 7:30 AM EDT
VIA GLOBENEWSWIRE
NEW YORK and VIENNA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ:HOOK) ("HOOKIPA" or the "Company"), a clinical-stage biopharmaceutical company developing next generation immunotherapeutics for the treatment of cancer and serious infectious diseases, today announced that the Company will present preclinical data related...

$HOOKIPA Pharma (HOOK.US)$
HOOKIPA Pharma Announces Effective Date of 1-for-10 Reverse Stock Split - July 10,2024

$HOOKIPA Pharma (HOOK.US)$ HOOKIPA Pharma Inc - HOOKIPA Achieves a $5 Mln Non-Dilutive Milestone Payment Under Its Collaboration and License Agreement With Gilead

$HOOKIPA Pharma (HOOK.US)$ Good news after-market 👀

$HOOKIPA Pharma (HOOK.US)$
Ladies and gentleman, On the 17 June 2024, 5 directors and 1 chairperson have collectively bought over 340K of shares at around 0.71 $.
Just wanted to share .... 😊